Onychomycosis not associated with poor COVID-19 clinical outcomes in a retrospective cohort study at an academic institution, New York, New York.

Curtis, Kaya L; Miller, Rhiannon C; Desai, Amar D; Lipner, Shari R

Curtis, Kaya L; Miller, Rhiannon C; Desai, Amar D; Lipner, Shari R.

Afiliación

Curtis KL; Weill Cornell Medical College, New York, New York.
Miller RC; Department of Dermatology, Weill Cornell Medicine, New York, New York.
Desai AD; Rutgers New Jersey Medical School, Newark, New Jersey.
Lipner SR; Department of Dermatology, Weill Cornell Medicine, New York, New York. Electronic address: shl9032@med.cornell.edu.

J Am Acad Dermatol ; 90(1): 153-156, 2024 01.

Article en En | MEDLINE | ID: mdl-37678498

Asunto(s)

COVID-19; Onicomicosis; Humanos; Onicomicosis/diagnóstico; Onicomicosis/tratamiento farmacológico; Onicomicosis/epidemiología; New York/epidemiología; Estudios Retrospectivos; Antifúngicos/uso terapéutico

Palabras clave

COVID-19; coronavirus; dermatophyte; fungus; nail disorders; onychomycosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Onicomicosis / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Am Acad Dermatol Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google